New Jersey Hematology and Oncology is a clinical research site located in Toms River, New Jersey, United States 08755.
Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.
New Jersey Hematology and Oncology has participated in 1 clinical trials.
Therapeutic areas: Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute.
Sponsors: Takeda.
Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
New Jersey Hematology and Oncology has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
New Jersey Hematology and Oncology has 1 clinical trials on record. Their work covers Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute.
New Jersey Hematology and Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.